Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing ICAM-1 expression

Annals of the New York Academy of Sciences

Volumn 1068, Issue 1, 2006, Pages 240-243

  Palacios, Veronica Garcia ^a   Chung, Ho Yeon ^b   Choi, Sun Jin ^a   Kurihara, Noriyoshi ^a   Lee, Jun Won ^a   Ehrlich, Lori A ^a   Collins, Robert ^c   Roodman, G David ^a,d,e  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b Sungkyunkwan University   (South Korea)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e Medicine/Hematology Oncology (111 H)   (United States)

Author keywords

ECF L; ICAM 1; Osteoclasts

Indexed keywords

CALCITRIOL; EOSINOPHIL CHEMOTACTIC FACTOR; EOSINOPHIL CHEMOTACTIC FACTOR L; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; BONE MARROW CELL; CONFERENCE PAPER; CONTROLLED STUDY; ENZYME ACTIVITY; MOUSE; NONHUMAN; OSTEOCLAST; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INTERACTION;

ANIMALIA;

EID: 33744764557     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1346.048     Document Type: Conference Paper

References (14)

1. Oba, Y. et al. 2003. Eosinophil chemotactic factor-L (ECF-L): a novel osteoclast stimulating factor. J. Bone Miner. Res. 18 : 1332 1341.
2. Owhashi, M., H. Arita & N. Hayai. 2000. Identification of a novel eosinophil chemotactic cytokine (ECF-L) as a chitinase family protein. J. Biol. Chem. 275 : 1279 1286.
3. Webb, D.C., A.N.J. McKenzie & P.S. Foster. 2001. Expression of the Ym2 lectin-binding protein is dependent on interleukin-4 and IL-13 signal transduction. J. Biol. Chem. 276 : 41969 41976.
4. Chang, N.A. et al. 2001. A macrophage protein, Ym1, transiently expressed during inflammation is a novel mammalian lectin. J. Biol. Chem. 276 : 17497 17506.
5. Hung, S.I. et al. 2002. Transient expression of Ym1, a heparin-binding lectin, during developmental hematopoiesis and inflammation. J. Leuko. Biol. 72 : 72 82.
6. Hsu, H. et al. 1999. Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand. Proc. Natl. Acad. Sci. USA 96 : 3540 3545.
7. Wong, B.R. et al. 1997. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem. 272 : 25190 25194.
8. Suda, T., N. Takahashi & T.J. Martin. 1992. Modulation of osteoclast differentiation. Endocr. Rev. 13 : 66 80.
9. Harada, H. et al. 1998. Involvement of lymphocyte function-associated antigen-1 and intercellular adhesion molecule-1 in osteoclastogenesis: a possible role in direct interaction between osteoclast precursors. Endocrinology 139 : 3967 3975.
10. Kurachi, K., I. Morita & S. Murota. 1993. Involvement of adhesion molecules LFA-1 and ICAM-1 in osteoclast development. Biochim. Biophys. Acta 1178 : 259 266.
11. Mbalaviele, G. et al. 1995. The role of cadherin in the generation of multinucleated osteoclasts from mononuclear precursors in murine marrow. J. Clin. Invest. 95 : 2757 2765.
12. Okada, Y. et al. 2002. Cell-to-cell adhesion via intercellular adhesion molecule-1 and leukocyte function-associated antigen-1 pathway is involved in 1, 25(OH)2D3, PTH and IL-1α-induced osteoclast differentiation and bone resorption. Endocr. J. 49 : 483 495.
13. Springer, T.A. 1990. Adhesion receptors of the immune system. Nature 346 : 425 434.
14. Tani-Ishii, N. et al. 2002. The role of LFA-1 in osteoclast development induced by co-cultures of mouse bone marrow cells and MC3T3-G2/PA6 cells. J. Periodontal Res. 37 : 184 191.